A Partner Who Knows Life Sciences
Early-stage, late-stage private and public companies of all sizes rely on our life sciences sector knowledge and strategic insight to craft the financial instruments that best serve their business goals. Oxford Finance is a reliable, trusted partner to venture capital firms, management teams, entrepreneurs and other lenders.
From Early Stage to IPO and Beyond.
Our focus is on life sciences, across a range of sub-sectors:
Biopharmaceuticals
Medical Devices
Specialty Pharmaceuticals
Enabling Technologies & Tools
Diagnostics
Healthcare IT
Loan Products
Borrowers work with dedicated teams of professionals through the entire loan process. Our collaborative approach ensures that the loan terms meet a borrower’s needs – and exceed its expectations. Our teams are empowered to work efficiently and thoroughly, with no bureaucratic layers, so we can deliver what we promise.
Senior Secured Term Loan
- Three-to five-year term
- Used for general working capital purposes, product licensing or acquisition opportunities
Cash Flow Loan
- Three- to five-year term
- Used to support acquisitions, refinancing and company growth
Revolving Line of Credit
- Two-to-five-year line of credit
- Ability to draw from and repay the balance repeatedly over the term of the loan
- Used for working capital and company growth
Recent Transactions
$50,000,000
Term Loan
Mountain View, CA
$100,000,000
Term Loan
South San Francisco, CA
NASDAQ: ALXO
$150,000,000
Term Loan
London, UK & Raleigh, NC
NASDAQ: VRNA
$22,700,000
Term Loan
Europe
-
I have a long track record with Oxford, and have found them very easy to work with and competitively priced. They know the life sciences space, and have the flexibility and patience needed to support start-ups through the various stages of development.
Richard Buchholz
Chief Financial Officer, Inspire Medical Systems -
Oxford Finance is one of the premier venture lending groups serving the life sciences community. Their continuity in the marketplace, as well as their professional and collaborative approach to transactions, makes them a logical go-to source for CFOs.
John Schmid
Chief Financial Officer, Auspex Pharmaceuticals -
Oxford is well known and highly regarded throughout the industry. The team was extremely knowledgeable, professional and responsive. They listened, took the time to understand our company’s business model and value drivers, and focused on what is important to IDEV Technologies.
Bill Burke
Executive Vice President & Chief Financial Officer, IDEV Technologies -
Oxford’s greatest asset is its team. They have deep industry knowledge that allows them to think and act strategically with their clients, and to do so in a timely manner. They also care about relationship building, and that has greatly enhanced our ability to work well together.
Peter Lawrence
President & COO, ArQule, Inc.
